Review By GURDEV SEHMI Last Updated On : Mar 13 2026 BSc Pharm, MRPharmS, Independent Prescriber, Superintendent Pharmacist, Clinical Lead GPhC Number: 2050925 Authored By GURDEV SEHMI Last Reviewed On : Mar 23 2026 BSc Pharm, MRPharmS, Independent Prescriber, Superintendent Pharmacist, Clinical Lead GPhC Number: 2050925
Individual results can vary, and combining the medication with lifestyle changes, like diet and exercise, can improve these outcomes
Obese women (BMI, 25-30) are much more likely to have GLP-1 side-effects, including heartburn and acid reflux reflux (range 70%-90%)
External resources New England Journal of Medicine: Tirzepatide versus semaglutide in type 2 diabetes (SURPASS-2 trial) PMC: Switching between GLP-1 receptor agonists, rationale and practical guidance Endocrine Practice: Switching to tirzepatide from GLP-1 receptor agonists, clinical expectations PMC: The risk of vestibular disorders with semaglutide and tirzepatide In case I do not see you, good afternoon, good evening, and good night
some of them may also reduce the efficacy of birth control pills, increasing chances of pregnancy